Aster Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354 Buy
+14
New +$116 ﹤0.01% 799
2025
Q2
Sell
-1,859
Closed -$52.7K 1504
2025
Q1
$52.7K Buy
1,859
+1,511
+434% +$44.9K 0.01% 816
2024
Q4
$12K Buy
+348
New +$15.7K ﹤0.01% 731

Other funds holding RXST

Aster Capital Management's RXST Position: Q1 2026 in Review

Aster Capital Management opened a new position in RxSight (RXST) in Q1 2026: 14 shares worth $354. The stake represents ﹤0.01% of the portfolio and ranks #799 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in RXST as recently as Q1 2025.

Aster Capital Management first reported a position in RXST in Q4 2024 and has held it in 3 quarters since. The position peaked at $52.7K in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Aster Capital Management held 14 shares of RxSight worth $354 as of Q1 2026.
  • RxSight was a new Aster Capital Management position in Q1 2026.
  • RxSight made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #799 holding.
  • Aster Capital Management first reported a position in RxSight in Q4 2024 and has held it in 3 quarters since.
  • Aster Capital Management's RxSight position peaked at $52.7K in Q1 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.